Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
166.53
-2.45 (-1.45%)
At close: Nov 19, 2026, 4:00 PM EST
166.60
+0.07 (0.04%)
After-hours: Nov 19, 2026, 4:48 PM EST
Gilead Sciences Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Gilead Sciences stock has a consensus rating of "Buy" and an average price target of $175.92. The average 1-year stock price forecast is 5.64% higher than the current stock price, while the lowest is $131 (-21.34%) and the highest is $200 (+20.10%).
Price Target: $175.92 (+5.64%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Gilead Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 16 | 16 | 16 | 16 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 7 | 7 | 6 | 5 | 5 | 5 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29 | 29 | 29 | 28 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $145 → $160 | Hold | Maintains | $145 → $160 | -3.92% | Nov 16, 2026 |
| Argus Research | Argus Research | Buy Reiterates $85 → $190 | Buy | Reiterates | $85 → $190 | +14.09% | Nov 12, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $200 | Buy | Maintains | $200 | +20.10% | Nov 10, 2026 |
| Maxim Group | Maxim Group | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 6, 2026 |
| Citi | Citi | Buy Maintains $180 → $188 | Buy | Maintains | $180 → $188 | +12.89% | Nov 5, 2026 |
Financial Forecast
Revenue This Year
31.36B
from 29.44B
Increased by 6.52%
Revenue Next Year
33.58B
from 31.36B
Increased by 7.06%
EPS This Year
-0.98
from 8.15
EPS Next Year
10.14
from -0.98
EPS and Forward PE are based on non-GAAP adjusted numbers.